Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice.
Miriam LongoPaola CarusoLorenzo ScappaticcioMaria Ida MaiorinoGiuseppe BellastellaAnnalisa CapuanoKatherine EspositoDario GiuglianoPublished in: Diabetes, obesity & metabolism (2024)
In a real-world setting, both SGLT-2i and DPP-4i improve glycaemic control persisting after 2 years of treatment, with a robust effect on both CIMT and albuminuria regression for SGLT-2i as compared with DPP-4i in the propensity score matching.